In a follow-up to a report last week, Thailand researchers say the World Health Organization (WHO) has expressed in the Ebola therapy developed at Mahidol University in Bangkok.
According to Clinical Professor Udom Kachintorn, Dean of the Faculty of Medicine Siriraj Hospital, Mahidol University, Dr. Martin Friede, Director of Ebola Research Project sent an email not only congratulating the research team on their Ebola therapeutic prototype, but also showed interest in developing the prototype, according to a Thailand National News Bureau report Friday.
The prototype is to be tested at a BSL-4 lab in the United States. The report notes that, if successful, the WHO will produce the antibody in mass quantities and use them without the benefit of clinical trials.
Currently WHO is providing all necessary documents and hopes that the prototype can be delivered to the U.S. within the next 2-3 weeks. Representatives of the Siriraj research team will also be invited to participate in the experiment in the U.S.